BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19

被引：0
|
作者：
Lewis-Wolfson, Temeka [1 ]
Joyner, Kayla [2 ]
Reid, Nancy [1 ]
机构：
[1] Winchester Med Ctr, Winchester, VA USA
[2] Shenandoah Univ, Bernard J Dunn Sch Pharm, Winchester, VA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
409
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [31] Tocilizumab for the treatment of COVID-19
    Fernandez-Ruiz, Mario
    Lopez-Medrano, Francisco
    Aguado, Jose Maria
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 431 - 434
  • [32] Tocilizumab for the treatment of COVID-19
    Flisiak, Robert
    Flisiak-Jackiewicz, Marta
    Rzymski, Piotr
    Zarebska-Michaluk, Dorota
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (08) : 791 - 797
  • [33] High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
    Naik, Naveen B.
    Puri, Goverdhan D.
    Kajal, Kamal
    Mahajan, Varun
    Bhalla, Ashish
    Kataria, Sandeep
    Singla, Karan
    Panigrahi, Pritam
    Singh, Ajay
    Lazar, Michelle
    Chander, Anjuman
    Ganesh, Venkata
    Hazarika, Amarjyoti
    Suri, Vikas
    Goyal, Manoj K.
    Pandey, Vijayant Kumar
    Kaloria, Narender
    Samra, Tanvir
    Saini, Kulbhushan
    Soni, Shiv L.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [34] Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia Reply
    Berlana, David
    Cardona-Pascual, Ignacio
    Montoro-Ronsano, J. Bruno
    MEDICINA CLINICA, 2022, 159 (08): : E55 - E55
  • [35] Baricitinib for COVID-19: a suitable treatment?
    Favalli, Ennio G.
    Biggioggero, Martina
    Maioli, Gabriella
    Caporali, Roberto
    LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 1012 - 1013
  • [36] Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
    Masia, Mar
    Padilla, Sergio
    Alberto Garcia, Jose
    Garcia-Abellan, Javier
    Navarro, Andres
    Guillen, Lucia
    Telenti, Guillermo
    Mascarell, Paula
    Botella, Angela
    Gutierrez, Felix
    FRONTIERS IN MEDICINE, 2021, 8
  • [37] Remdesivir treatment for patients with moderate to severe COVID-19
    Hasanoglu, Imran
    Guner, Rahmet
    Celik, Ilhami
    Kanat, Fikret
    Batirel, Ayse
    Dizman, Gulcin Telli
    Eren, Esma
    Sevgi, Dilek Yildiz
    Bozkurt, Ilkay
    Yasar, Kadriye Kart
    Senoglu, Sevtap
    Kazak, Esra
    Karaali, Ridvan
    Celikbas, Aysel
    Pullukcu, Husnu
    Cagatay, Arif Atahan
    Unal, Serhat
    Erdinc, Sebnem
    Tabak, Fehmi
    Gul, Ahmet
    Alp, Emine
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 880 - 887
  • [38] Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
    Roddy, John
    Wells, Daniel
    Schenck, Katharine
    Santosh, Shrihari
    Santosh, Sadashiv
    CRITICAL CARE EXPLORATIONS, 2022, 4 (05)
  • [39] Repurposed Tocilizumab in Patients with Severe COVID-19
    Tian, Jianbo
    Zhang, Ming
    Jin, Meng
    Zhang, Fengqin
    Chu, Qian
    Wang, Xiaoyang
    Chen, Can
    Yue, Huihui
    Zhang, Li
    Du, Ronghui
    Zhao, Dong
    Zeng, Zhaofu
    Zhao, Yang
    Liu, Kui
    Wang, Mengmei
    Hu, Ke
    Miao, Xiaoping
    Zhang, Huilan
    JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
  • [40] Clinical experience with tocilizumab in the treatment of pregnant woman with severe COVID-19
    Riabokon, O., V
    Kuliesh, I. O.
    Furyk, O. O.
    Matvieieva, T. B.
    Kalashnyk, K., V
    PATHOLOGIA, 2022, 19 (01): : 79 - 83
12345